MedAdvisor Limited (MDR.AX)
| Previous close | 0.2550 |
| Open | 0.2550 |
| Bid | 0.2500 x 8000000 |
| Ask | 0.2600 x 6828800 |
| Day's range | 0.2470 - 0.2600 |
| 52-week range | 0.1600 - 0.3450 |
| Volume | |
| Avg. volume | 399,272 |
| Market cap | 143.041M |
| Beta (5Y monthly) | 0.61 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
BEN and MedAdvisor Solutions Team Up to Bring Conversational AI to Patients Through Pharmacies
JACKSON, Wyo., February 27, 2024--Brand Engagement Network (BEN), an emerging provider of personalized customer engagement AI, and MedAdvisor Solutions (ASX: MDR), a global leader of pharmacy-driven patient engagement solutions, today announced a pilot partnership that will bring BEN’s AI assistants to certain pharmacies to help enhance patient outcomes.
- PR Newswire
CHARAC SECURES £1M INVESTMENT FROM WORLD-CLASS MEDICATION PLATFORM MEDADVISOR TO DRIVE ITS INTERNATIONAL GROWTH
Leading healthcare SaaS provider Charac today announces a ground-breaking partnership with world-class medication management platform MedAdvisor Solutions (ASX:MDR). The deal with Australia-based MedAdvisor allows Charac to expand it capabilities across Australia, New Zealand and the USA, making components of its app available to a far broader group of pharmacies internationally.
- PR Newswire
CHARAC SECURES £1M INVESTMENT FROM WORLD-CLASS MEDICATION PLATFORM MEDADVISOR TO DRIVE ITS INTERNATONAL GROWTH
Leading healthcare SaaS provider Charac today announces a ground-breaking partnership with world-class medication management platform MedAdvisor Solutions (ASX:MDR). The deal with Australia-based MedAdvisor allows Charac to expand it capabilities across Australia, New Zealand and the USA, making components of its app available to a far broader group of pharmacies internationally.
